Pre-clinical success for Covid-19 ARDS treatment
Israel’s BrainStorm (reported here previously) reported promising results of pre-clinical trials for its Nurown treatment for Acute Respiratory Distress Syndrome (ARDS) brought about by Covid-19. The NurOwn cells reduced the cytokine storm and lung damage.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink